Focal adhesion kinase (FAK) is a promising cancer drug target due to its massive overexpression in multiple solid tumors and its critical role in the integration of signals that control proliferation, invasion, apoptosis, and metastasis. Previous FAK dr...
Marlowe, T., Alvarado, C., Rivera, A., Lenzo, F., Nott, R., Bondugji, D., Montoya, J., Hurley, A., Kaplan, M., Capaldi, A. & Cance, W., Jan 1 2020, In: SLAS Discovery.25, 1, p. 21-3212 p.
Research output: Contribution to journal › Article › peer-review
Marlowe, T. (Creator), Alvarado, C. (Creator), Rivera, A. (Creator), Lenzo, F. (Creator), Nott, R. (Creator), Bondugji, D. (Creator), Montoya, J. (Creator), Hurley, A. (Creator), Kaplan, M. (Creator), Capaldi, A. (Creator), Cance, W. (Creator) (2019). Development of a High-Throughput Fluorescence Polarization Assay to Detect Inhibitors of the FAK–Paxillin Interaction. SAGE Journals. 10.25384/sage.c.4665260